Hypertension drug may reduce heart failure risk in people recovering from heart attack

New research found that the medication spironolactone, often prescribed for hypertension (high blood pressure), may reduce the risk of heart failure in people recovering from a heart attack.

Setting up trials in APAC and Middle East can boost patient recruitment

Share this article The country’s import laws and regional political instability can impact product availability for clinical trials, said Carine Cochereau. Image Credit: Phalguni Deswal

January 30, 2024

IntegriChain acquires pharma advisory services firm FCS

The acquisition marks IntegriChain’s seventh expansion. Credit: Gorodenkoff/Shutterstock. IntegriChain, a provider of data-driven commercialisation solutions for the pharmaceutical industry, has acquired pharma advisory and managed

July 10, 2024

Dementia risk rises with elevated remnant cholesterol, South Korean study reveals

How remnant cholesterol (remnant-C) levels are associated with the risk of developing dementia using a large dataset from South Korea.

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.